Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
-
New hope for hard-to-treat colorectal cancer: experimental combo enters human trials
Disease control Not yet recruitingThis study tests a new drug, LPM6690176, combined with standard chemotherapy and bevacizumab for people with a specific genetic form of metastatic colorectal cancer (RAS mutation). The trial has two parts: first, finding the safest dose in about 99 adults who have already tried o…
Phase: PHASE1, PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New schizophrenia pill aims to ease psychotic episodes
Symptom relief Not yet recruitingThis study tests an experimental drug called LY03020 in 160 adults with schizophrenia who are currently having severe symptoms (acute psychosis). Participants will receive either the drug or a placebo for a set time, and researchers will measure changes in a standard symptom scal…
Phase: PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated May 26, 2026 06:44 UTC
-
Radioactive drug tracking study paves way for huntington disease treatments
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a potential Huntington disease drug, LPM3770164, is processed and eliminated from the body. Eight healthy Chinese men will receive a single radioactive dose, and researchers will measure the drug and its breakdown products in blood, u…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 06:47 UTC